** Shares of medical device maker Neuropace NPCE.O fall 16.54% to $10.09
** Co announces the pricing of $65 million of common stock
** Co plans to offers 6.5 million shares at a public offering price of $10.00 per share; 17.3% discount to last closing price
** Grants underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock at the public offering price
** The offering is expected to close on February 18
** Co has 29.85 mln shares outstanding, giving it a ~360 mln market cap - data compiled from LSEG
** The stock has fallen ~27% in the last 12 months
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。